NCT00668096View on ClinicalTrials.gov

A Randomised Study of Levitra to Treat Men With Erections Problems and Previously Untreated With Similar Therapy.

PHASE4CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions
Erectile Dysfunction
Interventions
DRUG

Levitra (Vardenafil, BAY38-9456)

Vardenafil 5 mg or 10 mg or 20 mg, orally1 hour prior to sexual activity

DRUG

Placebo

Matching Placebo

Trial Locations (38)

1000

Bruxelles - Brussel

3000

Leuven

3350

Drieslinter

3600

Genk

4700

Næstved

8800

Viborg

13009

Marseille

13013

Marseille

13015

Marseille

22177

Hamburg

22299

Hamburg

22303

Hamburg

22846

Norderstedt

23812

Wahlstedt

24955

Harrislee

33100

Tampere

34000

Montpellier

38000

Grenoble

59000

Lille

69000

Lyon

90100

Oulu

DK-2820

Gentofte Municipality

DK-5700

Svendborg

04250

Kerava

01129

Dresden

04105

Leipzig

04249

Leipzig

04703

Leisnig

01662

Meissen

04600

Altenburg

08032

Barcelona

08850

Gavà

08905

L'Hospitalet de Llobregat

08043

Badalona (Barcelona)

TN6 1DL

Crowborough

OX7 5AL

Chipping Norton

WS14 9JL

Lichfield

ML3 ODR

Hamilton

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY